Company Overview

Company name: Zelda Therapeutics (ASX: ZLD)
Also known as: Zelda
Description: Provider of biotechnology research services. The company’s biotechnology research services conducts human clinical trials on the effectiveness of cannabis based formulations for treating conditions such as eczema acne and acute wound injuries, enabling researchers and clinicians to research the effect of ancient medicines.
Year founded: 2003
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.zeldatherapeutics.com
Employees: 8
City: Perth
State: Western Australia
Country: Australia
Region: Oceania

Financial Highlights

Start up capital raised (USD Million): 4.57
Business status: Generating Revenue
Ownership: Publicly Held
Exchange: ASX
Ticker: ZLD
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value: 38.62
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period: TTM 1Q2019
Financing Status: The company (TSX: ZLD) received AUD 6 million of development capital from an undisclosed investor on March 11, 2017 through a private placement.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: